Jci_page_head_homepage_01 Jci_page_head_homepage_02
Magdalena Juhaszova, Dmitry B. Zorov, Suhn-Hee Kim, Salvatore Pepe, Qin Fu, Kenneth W. Fishbein, Bruce D. Ziman, Su Wang, Kirsti Ytrehus, Christopher L. Antos, Eric N. Olson, Steven J. Sollott
Published in Volume 113, Issue 11
J Clin Invest. 2004; 113(11):1535–1549 doi:10.1172/JCI19906
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 9

GSK-3β, and not GSK-3α, regulates the protection state. (A) SiRNA treatment specifically decreases respective protein levels of GSK-3α and GSK-3β in neonatal rat cardiac myocytes; GFP siRNA and media alone served as negative controls. Immunoblot of cell lysates probed with antibodies against GSK-3α/β, GSK-3β, and 39-kDa subunit of mitochondrial Complex I (as a loading control). The immunoblot is representative of two independent experiments. (B) Silencing of GSK-3β, but not of GSK-3α, enhances tMPT to levels comparable to insulin-induced protection in neonatal rat cardiac myocytes. Data comprise two independent experiments; n = 30 in each group (except n = 22 for GFP siRNA). *P < 0.02, **P < 0.001, ***P < 0.0001 vs. respective control. (C) Constitutive activation of GSK-3β prevents ability to engage protective signaling. GSK-3β inhibition is required for protection against oxidative stress. Both mitochondrial sweller_dependent and _independent protection mechanisms are abolished in adult cardiac myocytes from GSK-3β S9A TG mice. *P < 0.02 vs. control. (D) Hypoxic PC protection after hypoxia/reoxygenation is abolished in adult cardiac myocytes from GSK-3β S9A TG mice. #P < 0.01 vs. control.